Separation of PEGylated α-lactalbumin from unreacted precursors and byproducts using ultrafiltration

Biotechnology Progress

Volumn 23, Issue 6, 2007, Pages 1417-1424

  Molek, Jessica R ^a   Zydney, Andrew L ^a  

^a The Center for Nanotechnology Education and Utilization   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED POLYMERS; POLYETHYLENE GLYCOLS; PURIFICATION; REACTION KINETICS; ULTRAFILTRATION;

FILTRATE FLUX; THERAPEUTIC PROTEINS;

PROTEINS;

LACTALBUMIN; MACROGOL DERIVATIVE;

ARTICLE; CHEMISTRY; GEL CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; OSMOLARITY; PH; ULTRAFILTRATION;

CHROMATOGRAPHY, GEL; HYDROGEN-ION CONCENTRATION; LACTALBUMIN; OSMOLAR CONCENTRATION; POLYETHYLENE GLYCOLS; ULTRAFILTRATION;

EID: 37149047514     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp070243w     Document Type: Article

References (45)

1. Asahina, Y.; Izumi, N.; Umeda, N.; Hosokawa, T.; Ueda, K.; Doi, F.; Tsuchiya, K.; Nakanishi, H.; Matsunaga, K.; Kitamura, T.; Kurosaki, M.; Uchihara, M.; Higaki, M.; Miyake, S. Pharmacokinetics and Enhanced PKR Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon Alpha-2b and Ribavirin. J. Viral Hepat. 2007, 14, 396-403.
2. Heredia, K.; Maynard, H. Synthesis of Protein-Polymer Conjugates. Org. Biomol. Chem. 2007, 5, 45-53.
3. Hamidi, M.; Azadi, A.; Rafiei, P. Pharmacokinetic Consequences of Pegylation. Drug Delivery 2006, 13, 399-409.
4. Muller, H.-J.; Loning, L.; Horn, A.; Schwabe, D.; Gunkel, M.; Schrappe, M.; von Schutz, V.; Henze, G.; Da Palma, J. C.; Pinheiro, J. P. V.; Winkelhorst, M.; Boos, J. Pegylated Asparaginase (Oncaspar™) in Children with ALL: Drug Monitoring in Reinduction According to the ALL/NHL-BFM 95 Protocols. Br. J. Haematol. 2000, 110, 379-384.
5. Mehvar, R. Recent Trends in the Use of Polysaccharides for Improved Delivery of Therapeutic Agents: Pharmacokinetics and Pharmacodynamic Perspectives. Curr. Pharm. Biotechnol. 2003, 4, 283-302.
6. Shibata, H.; Nakagawa, S.; Tsutsumi, Y. Optimization of Protein Therapies by Polymer-Conjugation as an Effective DDS. Molecules 2005, 10 (1), 162-180.
7. van der Auwera, P.; Platzer, E.; Xu, Z. X.; Schulz, R.; Feugeas, O.; Capdeville, R.; Edwards, D. J. Pharmacodynamics and Pharmacokinetics of Single Doses of Subcutaneous Pegylated Human G-CSF Mutant (RO 25-8315) in Healthy Volunteers: Comparison with Single and Multiple Daily Doses of Filgrastim. Am. J. Hematol. 2001, 66, 245-251.
8. Foser, S.; Schacher, A.; Weyer, K. A.; Brugger, D.; Dietel, E.; Marti, S.; Schreitmuller, T., Isolation, Structural Characterization, Antiviral Activity of Positional Isomers of Monopegylated Interferon Alpha-2a (Pegasys). Protein Expression Purif. 2003, 30, 78-87.
9. Michallet, M.; Maloisel, F.; Delain, M.; Hellmann, A.; Rosas, A.; Silver, R. T.; Tendler, C. Pegylated Recombinant Interferon Alpha-2b Vs Recombinant Interferon Alpha-2b for the Initial Treatment of Chronic-Phase Myelogenous Leukemia: A Phase III Study. Leukemia 2004, 18, 309-315.
10. Delgado, C.; Malmsten, M.; Van Alstine, J., M. Analytical Partitioning of Polyethylene Glycol)-Modified Proteins. J. Chromatogr. B 1997, 692, 263-272.
11. Li, W.; Yi, Z.; Lin, B.; Su, Z. Characterization of Polyethylene Glycol-Modified Proteins by Semi-Aqueous Capillary Electrophoresis. J. Chromatogr. A 2001, 905, 299-307.
12. Veronese, F. M.; Sacca, B.; Polverino de Laureto, P.; Sergi, M.; Caliceti, P.; Schiavon, O.; Orsolini, P. New PEGs for Peptide and Protein Modification, Suitable for Identification of the PEGylation Site. Bioconjugate Chem. 2001, 12, (1), 62-70.
13. Piquet, G.; Gatti, M.; Barbero, L.; Traversa, S.; Caccia, P.; Esposito, P., Set-up of Large Laboratory-Scale Chromatographic Separations of Polyethylene Glycol) Derivatives of the Growth Hormone-Releasing Factor 1-29 Analogue. J. Chromatogr. A 2002, 944, 141-148.
14. Vincentelli, J.; Paul, C.; Azarka, M. Evaluation of the Polyethylene Glycol-KF-Water System in the Context of Purifying PEG-Protein Adducts. Int. J. Pharm. 1999, 176, (2), 241-249.
15. Esposito, P.; Barbero, L.; Caccia, P.; Caliceti, P.; D'Antonio, M.; Piquest, G.; Veronese, F., M. Pegylation of Growth Hormone-Releasing Hormone (GRF) Analogues. Adv. Drug Delivery Rev. 2003, 55, 1279-1291.
16. Calceti, P.; Salmaso, S.; Walker, G.; Bernkop-Schnurch, A Development and in Vivo Evaluation of an Oral Insulin-PEG Delivery System. Eur. J. Pharm. Sci. 2004, 22, 315-323.
17. Lee, K. C.; Moon, C.; Cheol, S.; Park, M. O.; Lee, J. T.; Na, D.; Yoo, S. D.; Lee, H. S.; Deluca, P. Isolation, Characterization, and Stability of Positional Isomers of Mono-Pegylated Salmon Calcitonins. Pharm. Res. 1999, 16 (6), 813-818.
18. Fee, C. J.; Van Alstine, J. M. PEG-Proteins: Reaction Engineering and Separation Issues. Chem. Eng. Sci. 2006, 61, 924-939.
19. Wylie, D.; Voloch, M.; Lee, S.; Liu, Y.; Cannon-Carlson, S.; Cutler, C.; Pramanik, B. Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG Pharm. Res. 2001, 18 (9), 1354-1360.
20. Yamamoto, Y.; Tsutsumi, Y.; Yoshioka, Y.; Nishibata, T.; Kobayashi, K.; Okamoto, T.; Mukai, Y.; Shimizu, T.; Nakagawa, S.; Nagata, S.; Mayumi, T., Site-Specific PEGylation of a Lysine-Deficient TNF-Alpha with Full Bioactivity. Nat. Biotechnol. 2003, 21 (5), 546-552.
21. Pabst, T., M.; Buckley, J. J.; Ramasubramanyan, N.; Hunter, A. Comparison of Strong Anion-Exchangers for the Purification of a Pegylated Protein. J. Chromatogr. A 2007, 1147, 172-182.
22. Brumeanu, T. D.; Zaghouani, H.; Bona, C. Purification of Antigenized Immunoglobulins Derivatized with Monomethoxypolyethylene Glycol. J. Chromatogr. A 1995, 696, 219-225.
23. Nijs, M.; Azarkan, M.; Smolders, N.; Brygier, J.; Vincentelli, J.; Vries, G. P.; Duchateau, J.; Looze, Y. Preliminary Characterization of Bovine Beta-Lactoglobulin after Its Conjugation to Polyethylene Glycol. Biotechnol. Bioeng. 1997, 54 (1), 40-49.
24. Lee, H.; Park, T. G. Preparation and Characterization of Mono-Pegylated Epidermal Growth Factor: Evaluation of in Vitro Biological Activity. Pharm. Res. 2002, 19 (6), 845-851.
25. Edwards, C. K.; Martin, S., W.; Seely, J.; Kinstler, O.; Buckel, S.; Bendele, A.; Cosenza, M. E.; Feige, U.; Kohno, T. Design of Pegylated Soluble Tumor Necrosis Factor Receptor Type I (PEG STNF-RI) for Chronic Inflammatory Diseases. Adv. Drug Delivery Rev. 2003, 55, 1315-1336.
26. Arduini, R. M.; Li, Z.; Rapoza, A.; Gronke, R.; Hess, D., M.; Wen, D.; Miatkowski, K.; Coots, C.; Kaffashan, A.; Viseux, N.; Delaney, J.; Domon, B.; Young, C. N.; Boynton, R.; Chen, L. L.; Chen, L.; Betzenhause, M.; Miller, S.; Gill, A.; Pepinsky, R. B.; Hochman, P. S.; Baker, D. P. Expression, Purification, and Characterization of Rat Interferon-Beta and Preparation of an N-Terminally Pegylated Form with Improved Pharmacokinetic Parameters. Protein Expression Purif. 2004, 34, 229-242.
27. van Reis, R.; Gadam, S.; Frautschy, L.; Orlando, S.; Goodrich, E.; Saksena, S.; Kuriyel, R.; Simpson, C.; Pearl, S.; Zydney, A. L. High Performance Tangential Flow Filtration. Biotechnol. Bioeng. 1997, 56 (1), 71-82.
28. Smith, M. Molecular Weights of Proteins and Some Other Materials Including Sedimentation, Diffusion and Frictional Coefficients and Partial Specific Volumes. In Handbook of Biochemistry, 2nd ed.; Sober, H., Ed.; The Chemical Rubber Co.: Cleveland, OH, 1970; pp C3-C292.
29. Viaene, A.; Volckaert, G.; Joniau, M.; De Baetselier, A.; Van Cauwelaert, F. Efficient Expression of Bovine Alpha-Lactalbumin in Saccharomyces cerevisiae. Eur. J. Biochem. 1991, 202, 471-477.
30. Beynon, R.; Easterby, J. Buffer Solutions Basics, 1st ed.; Oxford University Press Inc.: New York, 1996; p 84.
31. van Reis, R. Charged Filtration Membranes and Uses Therefor. U.S. Patent, 7,001,550, 2006.
32. Molek, J.; Zydney, A. L. Ultrafiltration Characteristics of Pegylated Proteins. Biotechnol. Bioeng. 2006, 95 (3), 474-482.
33. Fee, C. J.; Van Alstine, J., M. Prediction of the Viscosity Radius and the Size Exclusion Chromatography Behavior of Pegylated Proteins. Bioconjugate Chem. 2004, 15, 1304-1313.
34. Singh, S.; Khulbe, K. C.; Matsuura, T.; Ramamurthy, P. Membrane Characterization by Solute Transport and Atomic Force Microscopy. J. Membr. Sci. 1998, 142, 111-127.
35. Saksena, S.; Zydney, A. L. Effect of Solution pH and Ionic Strength on the Separation of Albumin from Immunoglobulins (IgG) by Selective Filtration. Biotechnol. Bioeng. 1994, 43, 960-968.
36. van Reis, R.; Brake, J.; Charkoudian, J.; Burns, D.; Zydney, A. L. High-Performance Tangential Flow Filtration Using Charged Membranes. J. Membr. Sci. 1999, 159, 133-142.
37. Burns, D., B.; Zydney, A. L. Contributions to Electrostatic Interactions on Protein Transport in Membrane Systems. AIChE J. 2001, 47 (5), 1101-1114.
38. Mehta, A.; Zydney, A. L. Effect of Membrane Charge on Flow and Protein Transport During Ultrafiltration. Biotechnol. Prog. 2006, 22, 484-492.
39. Rao, S.; Zydney, A. L. Controlling Protein Transport in Ultrafiltration Using Small Charged Ligands. Biotechnol. Bioeng. 2005, 91 (6), 733-742.
40. Rao, S.; Zydney, A. L. High Resolution Protein Separations Using Affinity Ultrafiltration with Small Charged Ligands. J. Membr. Sci. 2006, 280, 781-789.
41. Pujar, N. S.; Zydney, A. L. Electrostatic and Electrokinetic Interactions During Protein Transport through Narrow Pore Membranes. Ind. Eng. Chem. Res. 1994, 33, (10), 2473-2482.
42. Zydney, A. L.; Xenopoulos, A. Improving Dextran Tests for Ultrafiltration Membranes: Effect of Device Format. J. Membr. Sci. 2007, 291, 180-190.
43. van Reis, R.; Saksena, S. Optimization Diagram for Membrane Separations. J. Membr. Sci. 1997, 129, 19-29.
44. Niven, R. W.; Whitcomb, K. L.; Shaner, L.; Ralph, L. D.; Habberfield, A. D.; Wilson, J. V. Pulmonary Absorption of Polyethylene Glycolated Recombinant Human Granulocyte-Colony-Stimulating Factor (Peg RHG-CSF). J. Controlled Release 1994, 32, (2), 177-189.
45. Parkinson, C.; Scarlett, J. A.; Trainer, P. J. Pegvisomant in the Treatment of Acromegaly. Adv. Drug Delivery Rev. 2003, 55, (10), 1303-1314.